ROSARIO FERNANDEZ GODINO’s Post

View profile for ROSARIO FERNANDEZ GODINO, graphic

Head of Screening and Target Validation/Drug Discovery at Fundación Medina

Check out our last publication on the use of metabolomics to predict survival in CRC patients with liver metastasis.

To view or add a comment, sign in

Explore topics